MCP-1 Causes Leukocyte Recruitment and Subsequently Endotoxemic Ileus in Rat
Overview
Physiology
Affiliations
Endotoxemia causes an inflammatory response within the intestinal muscularis and gastrointestinal dysmotility. We hypothesize that the resident macrophage-derived chemokine monocyte chemoattractant protein-1 (MCP-1) plays a significant role in the recruitment of leukocytes into the lipopolysaccharide (LPS)-stimulated rat intestinal muscularis. MCP-1 mRNA expression was investigated by RT-PCR. Leukocyte extravasation and MCP-1 protein localization were determined by immunohistochemistry. Contractile activity was assessed by using a standard organ bath in rats that were treated with saline, recombinant MCP-1, LPS, LPS + nonspecific antibody, or LPS + MCP-1 antibody. Endotoxemia caused a significant 280-fold increase in MCP-1 mRNA expression in the muscularis, peaking at 3 h. MCP-1 protein was immunohistochemically located to muscularis macrophages. LPS application caused significant leukocyte recruitment into the muscularis and a 51% decrease in muscle contractility. MCP-1 antibody treatment significantly averted leukocyte recruitment and significantly prevented muscle dysfunction. These parameters were not significantly altered by the nonspecific antibody. Results show that resident muscularis macrophage-derived MCP-1 plays a major role in the recruitment of monocytes during endotoxemia, which then subsequently secrete kinetically active substances that cause ileus.
The roles of tissue resident macrophages in health and cancer.
Cao M, Wang Z, Lan W, Xiang B, Liao W, Zhou J Exp Hematol Oncol. 2024; 13(1):3.
PMID: 38229178 PMC: 10790434. DOI: 10.1186/s40164-023-00469-0.
Bile pigments in emergency and critical care medicine.
Seya M, Aokage T, Nojima T, Nakao A, Naito H Eur J Med Res. 2022; 27(1):224.
PMID: 36309733 PMC: 9618204. DOI: 10.1186/s40001-022-00863-0.
Hussain Z, Park H J Neurogastroenterol Motil. 2022; 28(4):517-530.
PMID: 36250359 PMC: 9577567. DOI: 10.5056/jnm22100.
Sui C, Tao L, Bai C, Shao L, Miao J, Chen K Front Pharmacol. 2022; 13:929901.
PMID: 35991871 PMC: 9385171. DOI: 10.3389/fphar.2022.929901.
The Role of Inflammatory Mediators in the Development of Gastrointestinal Motility Disorders.
Docsa T, Sipos A, Cox C, Uray K Int J Mol Sci. 2022; 23(13).
PMID: 35805922 PMC: 9266627. DOI: 10.3390/ijms23136917.